Epoxomicin
To Order Contact us: stephen@expresspharmapulse.com
Epoxomicin |
|||
| A2606-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: Epoxomicin was originally isolated from the culture medium of an Actinomycetes strain based on its in vivo antitumor activity against murine B16 melanoma. Epoxomicin is a naturally occurring selective proteasome inhibitor with anti-inflammatory activity. |
|||
Epoxomicin |
|||
| abx076828-100ug | Abbexa | 100 ug | EUR 543.6 |
Epoxomicin |
|||
| GL3424-100UG | Glentham Life Sciences | 100 ug | EUR 316.8 |
Epoxomicin |
|||
| GL3424-250UG | Glentham Life Sciences | 250 ug | EUR 536.4 |
Epoxomicin |
|||
| GL3424-500UG | Glentham Life Sciences | 500 ug | EUR 895.2 |
Epoxomicin |
|||
| GL3424-50UG | Glentham Life Sciences | 50 ug | EUR 206.4 |
Epoxomicin |
|||
| HY-13821 | MedChemExpress | 10mM/1mL | EUR 867.6 |
Epoxomicin (Proteasome inhibitor) |
|||
| SIH-388-100UG | Stressmarq | 100 µg | EUR 339.6 |
|
Description: The substance Epoxomicin is a proteasome inhibitor. It is synthetically produced and has a purity of >95%. The pure substance is white solid which is soluble in DMSO (15 mg/ml) or dichloromethane:methanol (9:1); insoluble in water.. |
|||